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Abstract 
β-Annulus peptides from tomato bushy stunt virus conjugated with DNAs (dA20 and dT20) 
at the C-terminal were synthesized. The DNA-modified β-annulus peptides self-
assembled into artificial viral capsids with sizes of 45-160 nm. ζ-Potential measurements 
revealed that the DNAs were coated on the surface of artificial viral capsids. Fluorescence 
assays indicated that the DNAs on the artificial viral capsids were partially hybridized 
with the complementary DNAs. Moreover, the DNA-modified artificial viral capsids 
formed aggregates by adding complementary polynucleotides.  
 
Introduction 
Viral capsids are empty structures of natural viruses, excluding nucleic acids, which 
can spontaneously self-assemble from viral proteins without infectivity and potential 
replication probability. The viral capsids as nanoscale materials have been applied to 
novel drug delivery systems and nanoreactors [1–4]. For example, Douglas and coworkers 
developed nanoreactors based on alcohol dehydrogenase D encapsulated in bacteriophage 
P22 capsids [5]. Wang and coworkers reported encapsulation of quantum dots into 
mutated viral capsids modified with gold nanoparticles on the surface [6]. Conjugation 
strategies for viral capsids have been developed for display on the exterior surface by 
biofunctional molecules, such as oligosaccharides and proteins. Finn and co-workers 
demonstrated the covalent decoration of cowpea mosaic virus (CPMV) with carbohydrate 
molecules [7]. Kovesdi and co-workers constructed adenovirus particles modified with 
bispecific antibody to enhance transduction [8]. 
Oligodeoxyribonucleotides (ODNs) are used as building blocks to construct 
nanomaterials due to their capability of specific hybridization with the complementary 
DNA strand [9]. DNA’s simple code is able to construct patterned nanostructures in one, 
two, and three dimensions, which have been used to precisely position proteins and 
nanoparticles [10]. Recently, surface modification by ODNs on viral capsids has been 
developed to afford molecular recognition ability to viral capsids. Francis and co-workers 
achieved a one-dimensional arrangement of viral capsids modified with ODN strands on 
DNA origami tiles [11]. Finn and co-workers reported that CPMV capsids modified with 
ODNs aggregated by mixing with capsid-bearing complementary ODNs [12]. Francis and 
co-workers constructed cell-targeting vehicles by modification of bacteriophage MS2 
capsids with ssDNA aptamers on the surface [13]. 
On the other hand, rationally designed self-assembled protein/peptide nanostructures 
have a potential for biomaterial applications, which inspired the development of bottom-
up nanotechnology [14, 15]. Woolfson and co-workers demonstrated that two 
complementary trimeric coiled-coil units can form monolayer spheres of approximately 
100 nm in diameter by self-assembly [16]. Ryadnov and co-workers demonstrated that 
artificial virus-like particles self-assembled from designed peptides can encapsulate 
nucleic acids [17, 18]. Self-assembled peptide nanospheres have the potential to serve as 
materials for therapeutic carriers because of their biodegradability. Hashizume and co-
workers showed that recombinant protein nanoparticles modified with vascular 
endothelial cell binding peptide can target cancer cells [19]. However, modification of 
biofunctional molecules onto the surface of nanospheres self-assembled from rationally 
designed proteins/peptides is still in its infancy. 
We previously demonstrated that a synthetic 24-mer β-annulus peptide fragment 
(INHVGGTGGAIMAPVACTRQLVGS), which is a structural motif of the internal 
skeleton of tomato bushy stunt virus capsid, self-assembled into virus-like nanocapsules 
(artificial viral capsids) with sizes of 30–50 nm in water [20]. It is also suggested that the 
C-terminals of the peptides are directed to the surface of the nanocapsules, while the N-
terminals are directed towards the interior [21]. These properties made it possible to 
encapsulate anionic dyes, DNA [21], His-tagged proteins [22], and anionic CdTe quantum 
dots [23] into the artificial viral capsids. We also constructed artificial viral capsids 
decorated with gold nanoparticles by C-terminal modification of the β-annulus peptides 
[24]. These molecular designs enabled selective modification of artificial virus capsids 
with functional molecules in the interior and at the surface of capsids. 
In the present study, we report the synthesis and self-assembly of artificial viral capsids 
modified with homopolymeric 20-mer oligodeoxyadenosine (dA20) and 20-mer 
oligothymidine (dT20) at the C-terminal of the β-annulus peptide (Figure 1). The self-
assembling behavior of the DNA-modified β-annulus peptide into the artificial viral 
capsid was studied by dynamic light scattering (DLS) analyses and transmission electron 
microscopy (TEM). The hybridization behavior of the DNA-modified artificial viral 
capsids with the complementary DNAs was examined by fluorescence assays and DLS.  
 
Results and Discussion 
The synthetic scheme of dA20-modified β-annulus peptide conjugate (dA20-β-
annulus) is shown in Figure 1. The dA20 bearing an amino group via a hexamethylene 
chain at the 5′ end was reacted with the activated ester of a heterofunctional linker, N-(4-
maleimidobutyryloxy)sulfosuccinimide sodium salt, to introduce a maleimide group to 
the dA20. A β-annulus peptide containing Cys at the second position from the C-terminal 
(INHVGGTGGAIMAPVAVTRQLVCS) was synthesized using a standard Fmoc-
protected solid-phase method. Subsequently, dA20-β-annulus was prepared by reaction 
of the Cys of the peptide with the dA20-maleimide, and purified by reversed-phase HPLC. 
The HPLC retention times of dA20-NH2, dA20-maleimide, and β-annulus Cys peptide are 
22 min, 24.5 min and 42 min, respectively (Figure 2A). The dA20-modified β-annulus 
peptide showed one main peak at 35.5 min (Figure 2A (d)), which was confirmed by 
MALDI-TOF-MS (m/z = 8918 [M + Na]+) (Figure 2B). 
The self-assembling behavior of dA20-modified β-annulus peptide in 10 mM phosphate 
buffer (pH 7.1) was examined by transmission electron microscopy (TEM) observations 
and dynamic light scattering (DLS) measurements. A TEM image of the aqueous solution 
of dA20-β-annulus stained with phosphotungstic acid showed the formation of spherical 
assemblies of approximately 60 nm in diameter (Figure 3A). The average hydrodynamic 
diameter of the assemblies was determined by DLS experiments to be 98 ± 63 nm 
(Figure 3B), which represents a larger size and wider distribution than those of 
unmodified 24-mer β-annulus peptides (INHVGGTGGAIMAPVAVTRQLVGS, 47 ± 7 
nm) [20] and unmodified β-annulus Cys peptide (53 ± 13 nm, Figure S1). We have 
demonstrated that DNA was encapsulated into cationic interior of artificial viral capsid 
self-assembled from unmodified β-annulus peptides [21]. Since there is possibility that 
some DNAs may interact with cationic N-terminus of β-annulus peptides, it seems that 
dA20-β-annulus assemblies showed broad size distribution. The increase in diameter and 
distribution is probably due to the modification of dA20 on the surface of the artificial 
viral capsids. To construct complementary artificial viral capsids, we synthesized a dT20-
modified β-annulus peptide conjugate (dT20-β-annulus), according to the method 
described above; this was purified by reversed-phase HPLC and confirmed by MALDI-
TOF-MS (m/z = 8718 [M]+). The TEM image showed that dT20-β-annulus also formed 
spherical assemblies of approximately 60 nm in diameter (Figure 3C). The DLS of an 
aqueous solution of dT20-β-annulus also showed an average hydrodynamic diameter of 
65 ± 20 nm (Figure 3D), which is comparable to the assembly of dA20-β-annulus. The 
ζ-potential of unmodified β-annulus Cys peptide was almost neutral (−2 ± 5 mV) at pH 
7.1 (Figure 3E), which is consistent with the surface ζ-potentials of the β-annulus peptide 
at pH 7.0 [21]. In contrast, the ζ-potential of dA20-β-annulus was −40 ± 9 mV at pH 7.1 
(Figure 3E). These results indicate that the exterior surface of the artificial viral capsid 
self-assembled from dA20-β-annulus was coated with negatively charged dA20. Figure 4 
shows the concentration dependence of dA20-β-annulus on the diameter of the assembly 
obtained from DLS measurements. At a concentration of 0.15−25 µM, dA20-β-annulus 
formed assemblies with sizes of 18−190 nm, whereas at 50−100 µM, it formed aggregates 
with sizes of more than 200 nm. Since the critical aggregation concentration of 
unmodified β-annulus peptide was 25 µM [20], it is interesting to note that the dA20-β-
annulus can self-assemble at lower concentrations in spite of the negative charges of 
DNA. Although mechanism of the stabilization of capsid structures by modification of 
DNA is still unclear, it is probable that like-charge attractions [25, 26] or hydration forces 
[27] among DNA chains on the artificial viral capsids contribute to the stability. 
Next, the secondary structure of DNA on the artificial viral capsid was analyzed by 
circular dichroism (CD) spectroscopy. Figure 5A shows the CD spectra of dA20, β-
annulus peptide, dA20-β-annulus, and the difference spectrum obtained by subtracting β-
annulus peptide from dA20-β-annulus. The CD spectrum of β-annulus peptide (blue) 
shows weak intensity at 220-300 nm, and the CD spectrum of dA20 (green) and difference 
spectrum (red) are almost overlapped at 220-300 nm. This indicate that the CD intensity 
of negative peak at 248 nm of dA20 was minimally affected by conjugating with β-annulus 
peptide. Figure 5B shows the CD spectra of dA20-β-annulus in the presence of polydT in 
equimolar concentrations of nucleobase. Addition of the complementary PolydT to dA20-
β-annulus in equimolar concentrations of nucleobase (Figure 5B, red) showed a larger 
negative peak at 248 nm than dA20-β-annulus alone (Figure 5B, black), indicating the 
hybridization. This is almost consistent with the CD spectrum of the mixture of dA20 and 
PolydT (Figure 5B, blue), indicating the formation of a C-type DNA duplex, which is 
usually observed in DNA sequences consisting of only adenine and thymine. 
 In order to confirm the hybridization ability of the DNA-modified artificial viral 
capsids, fluorescence spectra of DAPI (4’, 6-diamidino-2-phenylidole dihydrochloride), 
which enhances the fluorescence intensity by binding to the minor groove of the DNA 
duplex [28], were measured. Although free DAPI has a weak emission maximum at 461 
nm, it shifts to a lower wavelength at 456 nm in the presence of PolydA and PolydT [28]. 
The fluorescence spectrum of DAPI in the presence of a mixture of dA20 and PolydT 
showed a high fluorescence intensity (Figure 6A (d)), indicating full hybridization. In 
contrast, the fluorescence intensity of DAPI in the presence of dA20-β-annulus/polydT 
(b) or dA20-β-annulus/dT20 (c) was smaller than that of spectrum (d), indicating that dT20 
and polydT were partially hybridized with dA20 on the capsids. Figure 6B shows that the 
fluorescence intensity of the equimolar mixture of dA20-β-annulus and dT20-β-annulus 
was increased by 1.4-fold as compared to the sum of each spectrum (e and f), which 
suggests that dA20 and dT20 on the capsids were partially hybridized. This might be caused 
by the steric hindrance between two DNA-modified capsids.   
TEM and DLS of the mixture of dA20-β-annulus and PolydT showed the formation 
of an aggregate with a size of about 500 nm (Figure 7A, B), whereas the mixture of dA20-
β-annulus and PolydA afforded individual artificial capsids and minimally sized 
aggregates of capsids (Figure 7C, D). TEM and DLS of the equimolar mixture of dT20-
β-annulus and PolydA showed the formation of spherical structures with a size of 10–30 
nm and partial aggregation (Figure 8A, B). In contrast, such aggregation was not observed 
in the equimolar mixture of dT20-β-annulus and PolydT (Figure 8C, D). These results 
indicate that DNA displayed on the surface of the artificial viral capsid can recognize the 
complementary DNA, which induces aggregation of the DNA-coated capsids by 
crosslinking among capsids with polynucleotide chains. The TEM image and DLS of the 
equimolar mixture of dA20-β-annulus and dT20-β-annulus showed the co-existence of 
two individual capsid assemblies with a size of 62 ± 14 nm and aggregates of these capsids 
with a size of 304 ± 93 nm (Figure 9). These results suggest that the dA20-coated artificial 
viral capsid can partially hybridize with the complementary dT20-coated capsid to form 
an aggregate. 
 
Conclusion 
We demonstrated the syntheses of C-terminal-modified β-annulus peptides with dA20 and 
dT20. The TEM images of the DNA-modified peptides showed that the peptide conjugates 
self-assembled into nanocapsules of approximately 45−160 nm in size. The ζ-potential 
and DNA-hybridization behaviors of the capsids indicated that DNAs were displayed on 
the surface of the artificial viral capsids. DNA displayed on the artificial viral capsid can 
recognize the complementary DNA. The present strategy will be extended to the 
fabrication of artificial viral capsids modified with DNA aptamers and DNA vaccine 
adjuvants. 
 
Experimental Section 
 
General. Reagents were obtained from a commercial source and used without further 
purification. Ion-exchanged water was used as a solvent for peptides in all experiments. 
Reversed-phase HPLC was performed at ambient temperature with a Shimadzu LC-6AD 
liquid chromatograph equipped with a UV/Vis detector (220 nm and 260 nm, Shimadzu 
SPD-10AVvp) using Inertsil WP300 C18 (GL Science, 250 × 4.6 mm or 250 × 20 mm) 
and Inertsil ODS-3 columns (GL Science, 250 × 4.6 mm or 250 × 20 mm). MALDI-TOF 
mass spectra were obtained on an Autoflex III (Bruker Daltonics) in linear/positive mode 
with α-cyano-4-hydroxycinnamic acid (α-CHCA) and 3-hydroxypicolinic acid (3-HPA), 
with diammonium hydrogen citrate as matrix. UV-vis spectra of DNA-conjugated 
peptides were measured at 260 nm using a Jasco V-630 with a quartz cell (S10-UV-1, GL 
Science).  
Synthesis of β-Annulus Cys Peptide. Peptide H-Ile-Asn(Trt)-His(Trt)-Val-Gly-Gly-
Thr(tBu)-Gly-Gly-Ala-Ile-Met-Ala-Pro-Val-Ala-Val-Thr(tBu)-Arg(Pbf)-Gln(Trt)-Leu-
Val-Cys(Trt)-Ser(tBu)-Alko-PEG resin was synthesized on Fmoc-Ser(tBu)-Alko-PEG 
resin (602 mg, 0.23 mmol/g, Watanabe Chemical Ind. Ltd) using standard Fmoc-based 
FastMoc coupling chemistry (4 eq. Fmoc-amino acids). A DMF solution of 2-(1H-
benzotriazole-1-yl)-1, 1, 3, 3-tetramethyluronium hexafluorophosphate (HBTU, 0.5 M) 
and 1-hydroxybenzotriazole hydrate (HOBt•H2O, 0.5 M) was used as a coupling reagent. 
Diisopropylamine (2.0 M) in NMP and 20% piperidine in N-methylpyrrolidone (NMP) 
were used for neutralization and for Fmoc deprotection, respectively. The peptidyl resin 
was washed with NMP and then dried under vacuum. The peptide was deprotected and 
cleaved from the resin by treatment with a cocktail of trifluoroacetic acid (TFA)/1, 2-
ethanedithiol/triisopropylsilane/water = 9.5/0.25/0.1/0.25 (mL) for 3 h at room 
temperature. The reaction mixture was filtered to remove the resin and the filtrate was 
concentrated under vacuum. The peptide was precipitated by adding ice-cooled methyl-
tert-butyl ether (MTBE) to the residue and the supernatant was decanted. After repeating 
the MTBE washing 3 times, the precipitated peptide was dried under vacuum. The crude 
product was purified by reversed-phase HPLC (Inertsil WP300 C18), eluting with a linear 
gradient of CH3CN/water (25/75 to 55/45 over 90 min) containing 0.1% TFA. The elution 
fraction containing the desired peptide was lyophilized to give a flocculent solid. The 
isolated yield was 5.1 mg (13%). MALDI-TOF-MS (matrix: α-CHCA): m/z = 2351.0 
([M]+). 
Preparation of DNA- β-annulus Peptide Conjugates. An aqueous solution of dA20-
(CH2)6-NH2 (0.1 mL of 1.0 mM, Gene Design Inc.) was mixed with 9.1 mg of N-(4-
maleimidobutyryloxy)-sulfosuccinimide sodium salt (Sulfo-GMBS, 2.4 µmol, 240 
equiv.) and 0.5 mL of 0.1 M sodium bicarbonate aqueous solution. The mixture was 
incubated for 2 h at 25ºC, and then dialyzed with a dialysis membrane (Spectra/por7, 
cutoff Mw 1,000, Spectrum Laboratories, Inc.) for 20 h in water. The mixture was 
monitored by reversed-phase HPLC (Inertsil ODS-3), eluting with a linear gradient of 
CH3CN/0.1 M ammonium formate aqueous solution (0/100 to 100/0 over 105 min). In 
order to remove ammonium formate and CH3CN, water was added into the elution 
fraction and then the frozen mixture was concentrated in a centrifugal evaporator. The 
procedure was repeated 5 times, and then the product was confirmed by MALDI-TOF-
MS (matrix: 3-HPA). After dialysis using Spectra/por7, the maleimide-dA20 was 
lyophilized for the next reaction without further purification. The maleimide-dT20 was 
also obtained by a similar method to that described above by using 0.1 mL of 1.0 mM 
aqueous solution of dT20-(CH2)6-NH2 (Gene Design Inc.).  
The dA20-maleimide was dissolved in 0.2 mL of 0.1 M phosphate buffer (pH 6.6). β-
Annulus Cys peptide (1 mg, 0.47 µmol) in water/acetonitrile (2/3, v/v, 1 mL) was added 
to the solution and incubated for 48 h at 40ºC. The solution was purified by reversed-
phase HPLC (Inertsil ODS-3), eluting with a linear gradient of CH3CN/0.1 M ammonium 
formate aqueous solution (0/100 to 100/0 over 105 min). The elution fraction was 
collected, the frozen mixture was concentrated in a centrifugal evaporator, and then the 
mixture was dialyzed using a dialysis membrane (Spectra/por7, cutoff Mw 1,000, 
Spectrum Laboratories, Inc.) for 20 h with water. The internal solution was lyophilized to 
give a flocculent solid. After dissolving in water, the concentration of the product was 
determined from the absorbance at 260 nm. The yield of dA20-β-annulus was 55 nmol 
(23.6%). MALDI-TOF-MS (matrix: 3-HPA): m/z = 8918 ([M + Na]+). The dT20-modified 
β-annulus peptide (dT20-β-annulus) was also prepared according to the method described 
above. The yield of the product was 21 nmol (22.2%). MALDI-TOF-MS (matrix: 3-
HPA): m/z = 8718 ([M]+). 
Dynamic Light Scattering. Stock solutions (0.1 mM) of DNA-β-annulus peptide 
conjugates (dA20-β-annulus and dT20-β-annulus) in 10 mM phosphate buffer (pH 
7.1) were prepared by dissolution in the buffer. Polydeoxyadenylic acid sodium salt 
(PolydA, Sigma-Aldrich) was dissolved in 10 mM phosphate buffer (pH 7.1) as a 
stock solution (2.5 mM). The samples were diluted to equimolar amounts of 
nucleobase in 10 mM phosphate buffer (pH 7.1) and sonicated for 5 min before DLS 
measurement. DLS was measured with a Zetasizer NanoZS (MALVERN) instrument 
at 25ºC using an incident He-Ne laser (633 nm). Correlation times of scattered light 
intensities G(τ) were measured several times, and the means were calculated and fitted 
to equation 1, where B is the baseline, A is the amplitude, q is the scattering vector, τ 
is the delay time and D is the diffusion coefficient. 
G(τ) = B + A exp(−2q2Dτ )                    (1) 
The hydrodynamic radii (RH) of the scattering particles were calculated using the Stokes–
Einstein equation (eq. 2), where η is the solvent viscosity, kB is Boltzmann’s constant, 
and T denotes the absolute temperature. 
 RH = kBT/6πηD                            (2) 
Zeta Potential Analysis. The zeta potential was measured at 25ºC using a Zetasizer Nano 
ZS (MALVERN) with a DT1061 clear disposable zeta cell. Τhe dA20-β-annulus and β-
annulus-Cys peptide were diluted to 25 µM with 10 mM phosphate buffer (pH 7.1) before 
measurement. 
Transmission Electron Microscopy. Aliquots (5 µL) of DLS samples were applied 
to hydrophilized carbon-coated Cu-grids (C-SMART Hydrophilic TEM girds, 
ALLANCE Biosystems) for 60 s and were then removed. Subsequently the TEM 
grid was instilled in the staining solution (2% phosphotungstic acid (Na3 (PW12O40) 
(H2O)n) aqueous solution, 5 µL) for 1 min, and then removed. After the sample-loaded 
carbon-coated grids were dried in vacuo, they were observed by TEM (JEOL JEM 1400 
Plus), using an accelerating voltage of 80 kV. 
Fluorescence Spectra. Sample solutions of dA20-β-annulus (25 µM), dT20-β-annulus 
(25 µM), and their equimolar mixture were prepared by dissolution in 10 mM phosphate 
buffer (pH 7.1). Equimolar amounts in a nucleobase concentration of 
oligodeoxyribonucleotides (dA20 and dT20, Gene Design Inc.), PolydT (Sigma-Aldrich) 
and PolydA (Sigma-Aldrich) were also added to the sample solutions. Then, an aqueous 
stock solution of 4',6-diamidino-2-phenylindole (DAPI, DOJINDO) in10 mM phosphate 
buffer (pH 7.1) was added to the sample solutions (final concentration of DAPI: 10 µM). 
The fluorescence spectra were measured with a Jasco FP8200 spectrofluorometer at 25ºC 
using an excitation wavelength of 345 nm. 
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Figure 1. Schematic of synthesis of dA20-modified β-annulus peptide (dA20-β-annulus) and formation of 
the dA20-modified artificial viral capsid by self-assembly. 
  
 Figure 2. (A) Reverse-phase chromatograms of (a) dA20-NH2 detected at 260 nm, (b) dA20-maleimide 
detected at 260 nm, (c) β-annulus Cys peptide detected at 220 nm, (d) reaction mixture containing dA20-β-
annulus detected at 260 nm. (B) MALDI-TOF-MS of the purified dA20-β-annulus (m/z = 8918[M + Na]+). 
  
  
 
Figure 3. TEM images and size distributions obtained from DLS for aqueous solutions of 25µM dA20-β-
annulus (A, B) and 25µM dT20-β-annulus (C, D) in phosphate buffer (pH7.1) at 25ºC. (E) Zeta potential 
of un-modified β-annulus Cys peptide (25µM, black) and dA20-β-annulus (25µM, red) measured in 10mM 
phosphate buffer (pH7.1) at 25ºC.   
  
  
 Figure 4. Concentration dependence of dA20-β-annulus on the diameter of the assembly obtained from 
DLS in 10 mM phosphate buffer (pH 7.1) at 25ºC. 
  
 
 
Figure 5. CD spectra of (A) dA20 (green), dA20-β-annulus (black), β-annulus peptide (blue) and the 
spectrum subtracting β-annulus peptide from dA20-β-annulus (red), and (B) dA20-β-annulus (black), 
PolydT (green), mixture of dA20 and PolydT (blue) and mixture of dA20-β-annulus and PolydT (red) in 
10mM phosphate buffer (pH7.1) at 25ºC; [A]=[T]=0.5mM. 
  
 Figure 6. Fluorescence spectra of 10 µM DAPI solutions in 10 mM phosphate buffer (pH 7.1, excitation 
wavelength: 345 nm). (a) DPAI alone, (b) DAPI + 25 µM dA20-β-annulus and PolydT, (c) DAPI + 25 µM 
dA20-β-annulus and 25 µM dT20, (d) DAPI + 25 µM dA20 and PolydT, (e) DAPI + 25 µM dA20-β-annulus, 
(f) DAPI + 25 µM dT20-β-annulus, (g) DAPI + 25 µM dA20-β-annulus and 25 µM dT20-β-annulus. All 
the nucleobase concentrations are the same: [A] = [T] = 0.5 mM. 
  
 Figure 7. TEM images and size distributions obtained from DLS for an aqueous solution of dA20-β-
annulus (25 µM) in 10 mM phosphate buffer (pH 7.1) at 25ºC. (A, B) in the presence of PolydT 
([nucleobase] = 0.5 mM), (C, D) in the presence of PolydA ([nucleobase] = 0.5 mM). TEM images stained 
with sodium phosphotungstate. 
  
 Figure 8. TEM images and size distributions obtained from DLS for an aqueous solution of dT20-β-annulus 
(25 µM) in phosphate buffer (pH 7.1) at 25ºC. (A, B) in the presence of PolydA ([nucleobase] = 0.5 mM), 
(C, D) in the presence of PolydT ([nucleobase] = 0.5 mM). TEM images stained with sodium 
phosphotungstate. 
  
 Figure 9. TEM image (A) and size distributions obtained from DLS (B) for an aqueous solution of dA20-
β-annulus (25 µM) mixed with dT20-β-annulus (25 µM) in 10 mM phosphate buffer (pH 7.1) at 25ºC. 
TEM images stained with sodium phosphotungstate. 
 
